Viatris (NasdaqGS:VTRS) Update / briefing March 19, 2026 10:00 AM ET Company ParticipantsBill Szablewski - Head of Capital Markets and Investor RelationsCorinne Le Goff - Chief Commercial OfficerDoretta Mistras - CFOHemanth J. Varghese - Chief Strategy OfficerPhilippe Martin - Chief R&D OfficerScott Smith - CEOOperatorLadies and gentlemen, please welcome Head of Capital Markets, Viatris, Bill Szablewski.Bill SzablewskiGood morning, everyone, and welcome to our Viatris Investor Event. I'm Bill Szablewski, He ...

Summary of Vishay Precision Group (VPG) Conference Call - March 19, 2026 Company Overview - **Company**: Vishay Precision Group (NYSE: VPG) - **Industry**: Precision sensing and measurement technologies - **Key Segments**: Sensors, Weighing Solutions, Measurement Systems Core Points and Arguments 1. **Market Opportunities**: VPG is targeting new markets such as humanoid robots, driven by trends in Physical AI, which require advanced sensing technologies [2][10] 2. **Organizational Changes**: Recent structural changes include the introduction of a Chief Business and Product Officer and a Chief Operating Officer to enhance growth and operational readiness [5][11] 3. **Financial Discipline**: The company emphasizes a disciplined financial focus, with ongoing cost reduction initiatives yielding $4.5 million in savings in 2025 and an additional $6 million targeted for 2026 [5][32] 4. **Strong Demand Indicators**: VPG has reported five consecutive quarters of book-to-bill ratios at or above 1, indicating improving demand, particularly in the Sensors segment [4] 5. **Diverse Market Presence**: The company serves a wide array of markets, including industrial applications, semiconductor testing, and avionics, holding a leading position in many niches [6] 6. **Emerging Humanoid Market**: VPG has secured nearly $2 million in prototype orders for humanoid robots, with expectations for significant growth in this area [5][14] 7. **Physical AI Trends**: The company is aligned with the growing trend of Physical AI, which is expected to revolutionize various industries, including manufacturing and logistics [10][15] 8. **Operational Improvements**: Initiatives for operational excellence include footprint optimization, automation, and procurement streamlining, aiming for $20 million in cost savings over three years [16][17] 9. **Revenue Growth Expectations**: VPG anticipates a 20% growth in business development initiatives in 2026, with a focus on high-performance sensing solutions [12][13] 10. **M&A Strategy**: The company remains open to mergers and acquisitions as a means to drive growth, looking for opportunities in both existing and new markets [41] Additional Important Content - **Safety and Employee Well-being**: The company prioritizes employee safety, especially in light of potential disruptions from geopolitical events [19][20] - **R&D Balance**: VPG maintains a strong engineering focus, balancing R&D between new sensing technologies and weighing solutions [24] - **Scalability of Measurement Systems**: The Measurement Systems segment has the highest gross margins but involves longer lead times compared to other segments [33][34] - **Future Margin Targets**: The company is updating its 3-5 year financial model, with expectations to achieve or exceed previous margin targets [35][39] - **Production Capacity Flexibility**: VPG has the capacity to expand production quickly in response to significant orders, ensuring they can meet customer demands [40] This summary encapsulates the key insights and strategic directions discussed during the conference call, highlighting VPG's focus on innovation, market expansion, and operational efficiency.

Summary of Koninklijke Ahold Delhaize Conference Call Company Overview - **Company Name**: Koninklijke Ahold Delhaize - **Ticker Symbols**: AD (Amsterdam), ADRNY, AHODF (OTCQX) - **Established**: 10 years ago through a merger of Dutch company Ahold and Belgian company Delhaize - **Operations**: 17 brands across 9 countries with over 9,000 stores serving 70 million customers weekly - **Market Presence**: 60% of operations in the U.S. with major brands including Food Lion, Stop & Shop, Giant Food, The GIANT Company, and Hannaford. In Europe, key brands include Albert Heijn and Delhaize [5][6] Strategic Focus - **Growing Together Strategy**: Launched in late 2024, focusing on four key components: 1. **Customer Value Proposition**: Emphasizing healthy and affordable products, loyalty programs, and omnichannel experiences [15] 2. **Market Expansion**: Remodeling and opening new stores, particularly in the U.S., including the acquisition of 300 convenience format stores in Belgium [16] 3. **Innovation for Growth**: Leveraging AI for customer experience and operational efficiencies, aiming for EUR 3 billion in complementary income streams by 2028 [17] 4. **Cost Efficiency**: Targeting EUR 5 billion in savings from 2025 to 2028 through operational efficiencies [19] Performance Metrics - **Own Brand Strategy**: Aiming to increase Own Brand penetration to 45% from nearly 40%, with current U.S. penetration at 33% and Europe at 50% [22] - **Online Business Growth**: Achieved 18% growth in U.S. online sales, with over 90% of orders for same-day delivery. Profitability achieved on a fully allocated basis globally [26][27] - **Market Positioning**: The acquisition of Profi added over 1,700 stores in Romania, doubling market presence and generating nearly EUR 2.8 billion in sales [29] Challenges and Consumer Behavior - **Market Uncertainty**: Ongoing geopolitical tensions, such as the conflict in Ukraine, affecting consumer confidence and spending [33] - **Value-Focused Consumer Trends**: Increased openness to Own Brand products, with sales outpacing national brands. Consumers are more cautious and focused on promotions [39][40] Sustainability Initiatives - **Long-term Sustainability Goals**: Emphasizing the importance of sustainable supply chains and reducing CO2 emissions, food waste, and plastic use [49][50] Capital Allocation and M&A Strategy - **Share Buyback Program**: EUR 1 billion share buyback program approved for 2026, with intentions to continue through 2028 [70] - **M&A Opportunities**: Open to future bolt-on acquisitions to strengthen market position, particularly in regions where they aim to be number one or two [71] E-commerce and Digital Investments - **Digital Platform Development**: Implementation of the PRISM platform across U.S. brands, enhancing customer engagement and operational efficiency [75] - **Partnerships**: Strong growth through partnerships with Instacart and DoorDash, indicating a shift towards online shopping [76] Conclusion - **U.S. Market Importance**: The U.S. remains a central focus for Ahold Delhaize, crucial for both operational success and investor engagement [80]

Genco Shipping & Trading Conference Summary Company Overview - Genco Shipping & Trading is the largest U.S.-based dry bulk shipowner, headquartered in New York with offices in Singapore and Copenhagen - The company operates a fleet of 43 modern high-quality dry bulk vessels, capable of transporting a wide range of commodities including iron ore, coal, grains, cement, fertilizers, sugar, and salt [2][3] Core Business Strategy - Genco has a robust commercial platform that allows direct engagement with cargo owners, providing full-service logistics solutions and generating revenue above daily indices [3] - The company employs a low leverage model with a net loan-to-value ratio of approximately 12%, coupled with a high dividend payout strategy [4][7] - Genco's fleet includes 19 Newcastlemax and Capesize vessels focused on major bulk commodities, and 26 Ultramax and Supramax vessels for minor bulk commodities, providing a balance of high beta and stability [5][11] Financial Performance - In 2025, Genco's cargo composition was 48% iron ore, 14% grains, and 13% coal, with iron ore being crucial for steel production [6] - The company has paid $270 million in dividends and reduced debt by nearly $250 million, maintaining a strong financial position [7][8] - Genco's Q4 2025 dividend was $0.50 per share, representing an annualized yield of close to 10%, the highest since Q4 2022 [14][19] - EBITDA for Q4 2025 reached $42 million, contributing to half of the total EBITDA for the year [16] Market Dynamics - The Baltic Dry Index has shown strong performance, with Cape rates averaging $23,000 per day and Supramax rates at $12,000 per day, driven by robust Atlantic iron ore exports, particularly from Brazil [21][22] - Guinean bauxite exports have increased by 30% year-to-date, with 75% shipped to China, indicating strong demand for Capesize vessels [22] - The current order book for dry bulk vessels is about 12%-13% of the fleet, with 11% of the existing fleet being over 20 years old, suggesting a need for replacement tonnage [23] Corporate Governance - Genco is recognized for its strong corporate governance, being the only U.S. filer with no related party transactions and ranking in the top quartile among public shipping companies [12][13] Risk Management - The company is well-positioned to manage geopolitical risks and market volatility due to its low leverage and strong balance sheet, allowing for continuous capital returns to shareholders [49][50] - Genco monitors macroeconomic factors and commodity demand closely, particularly in developing Asia and China, which are significant for the dry bulk market [48] Future Outlook - Genco is optimistic about 2026 and beyond, expecting continued growth in iron ore and bauxite trades, with a focus on larger ships to capitalize on these trends [25][34] - The company plans to maintain its strategy of prioritizing dividends while also investing in fleet renewal and growth opportunities as market conditions allow [41][50]

Summary of Key Points from the Conference Call Industry or Company Involved - The discussion revolves around the European Central Bank (ECB) and its monetary policy in response to current economic conditions, particularly influenced by the war in the Middle East. Core Points and Arguments 1. **Interest Rates Decision**: The ECB decided to keep the three key interest rates unchanged, aiming to stabilize inflation at a 2% target in the medium term. The ongoing war in the Middle East has introduced significant uncertainty, impacting inflation and economic growth forecasts [2][16]. 2. **Inflation Projections**: - Headline inflation is projected to average 2.6% in 2026, 2% in 2027, and 2.1% in 2028, revised upwards due to higher energy prices resulting from the conflict [3][4]. - Inflation excluding energy and food is expected to average 2.3% in 2026, 2.2% in 2027, and 2.1% in 2028, also revised upwards [3][4]. 3. **Economic Growth Forecasts**: Economic growth is projected to average 0.9% in 2026, 1.3% in 2027, and 1.4% in 2028, reflecting a downward revision primarily due to the global effects of the war [4][12]. 4. **Impact of Energy Prices**: The war is expected to lead to higher energy prices, which will have a material impact on inflation and economic growth. A prolonged disruption in oil and gas supply could result in inflation exceeding baseline projections and growth falling below expectations [5][12]. 5. **Data-Dependent Approach**: The ECB emphasizes a data-dependent and meeting-by-meeting approach to monetary policy, with decisions based on the inflation outlook and incoming economic data [5][16]. 6. **Scenario Analysis**: The ECB staff has developed alternative scenarios to assess the potential impacts of the war on inflation and growth, which will be published on their website [4][30]. 7. **Labor Market and Wage Growth**: The labor market remains solid, with wage growth expected to ease, which may support the return of inflation to target levels. However, inflation expectations in financial markets have increased significantly [10][11][50]. 8. **Financial Market Conditions**: Financial conditions have tightened, with stock markets falling and market interest rates rising, particularly for short-term rates. Bank lending rates for firms remained stable, while corporate bond issuance showed stronger growth [14][15]. Other Important but Possibly Overlooked Content 1. **Geopolitical Risks**: The ongoing war in the Middle East and other geopolitical tensions, such as the conflict in Ukraine, pose significant risks to the euro area economy, potentially affecting consumer confidence and investment [11][12]. 2. **Fiscal Responses**: The ECB highlights the need for any fiscal responses to the energy price shock to be temporary, targeted, and tailored, emphasizing the importance of reducing dependence on fossil fuels [8]. 3. **Digital Euro and Financial Integration**: The introduction of a digital euro and tokenized central bank money is seen as essential for enhancing Europe’s strategic autonomy and competitiveness [9]. 4. **Private Credit Concerns**: The ECB is monitoring the growth of private credit markets and their potential risks to financial stability, particularly in light of the U.S. market dynamics [41][44]. This summary encapsulates the key discussions and insights from the ECB's conference call, focusing on the implications of current geopolitical events on monetary policy and economic forecasts.

Summary of Chemed (NYSE:CHE) FY Conference Call - March 19, 2026 Company Overview - **Company**: Chemed Corporation - **Segments**: VITAS (hospice care) and Roto-Rooter (plumbing and water restoration services) Key Points on VITAS - **Guidance Confidence**: The company is comfortable with VITAS guidance, indicating potential conservatism in projections. They aim to balance the patient mix between short and long-stay patients, which could enhance growth in 2026 [2][3] - **Volume Trends**: Strong volume performance was noted coming out of Q4 2025, which is expected to guide overall growth potential for 2026 [6] - **Florida Market**: Florida's unique Certificate of Need (CON) environment allows for rapid growth. The company is optimistic about its growth trajectory in Florida compared to other regions, where growth rates are slower [7][8] - **Medicare ADC Growth**: The company has seen consistent growth in Average Daily Census (ADC) in Medicare, particularly in Florida, indicating a positive trend in patient admissions [10][11] - **Hospital Admissions**: The ideal hospital admission rate is targeted between 42%-45%. The company has successfully managed to reduce this percentage while increasing overall volumes [11][12] - **Long-term Outlook**: The company feels confident about its long-term position in Florida, citing sufficient hospital patient base availability to maintain a balanced patient mix [16][17] - **New Market Expansion**: New locations in Florida (Pasco, Marion, Pinellas) are expected to reach profitability within 12 months, contributing significantly to organic growth [21][22][23] - **Margin Management**: The company anticipates returning to pre-pandemic margin levels, targeting margins of 18%-18.5% in the long term, with gradual improvements expected [27][26] Key Points on Roto-Rooter - **Growth Projections**: Roto-Rooter is projecting a top-line growth of 3%-3.5% for 2026, with improvements expected from reduced water restoration write-offs and a slight increase in lead volume [28][29] - **Marketing Costs**: Elevated marketing costs are anticipated to remain stable, impacting EBITDA. The company is focused on managing these costs effectively [30][34] - **Water Restoration Challenges**: The company is centralizing billing and collections for water restoration to improve efficiency and collection rates, which have historically varied across branches [36][37] - **Technology Integration**: Roto-Rooter is testing new technology to improve documentation for insurance claims, which is expected to enhance collection rates [40] - **Seasonality Impact**: The first quarter is expected to be challenging due to tough comparisons with the previous year, but the company remains on track with its overall metrics [44][46] - **Franchise Acquisition Strategy**: The company is actively pursuing franchise acquisitions, offering higher multiples than before, which may reduce ROI but is expected to yield strategic benefits [48][49] - **Strategic Alternatives**: If Roto-Rooter does not show recovery in 2026, the company is open to considering strategic alternatives, including potential divestitures [50] Additional Insights - **Market Conditions**: The company is navigating challenges related to weather impacts on operations and the competitive landscape for lead generation [45][46] - **Long-term Viability**: There is a strong belief in the long-term viability of both segments, with a focus on improving operational efficiencies and patient care [50]

Summary of Tennant Company Conference Call (March 19, 2026) Company Overview - **Company**: Tennant Company (NYSE:TNC) - **Market Position**: Global leader in a $9 billion Total Addressable Market (TAM) with a 14% global market share, 25% in the Americas, 10% in EMEA, and 4% in Asia-Pacific [3][4] Core Business Insights - **Differentiated Service Model**: Emphasis on a world-class service model that enhances the aftermarket business, crucial for customer experience [2] - **Robotics and Automation**: Focus on driving industry disruption through robotics, addressing labor shortages and enhancing productivity [2][5] - **Growth Drivers**: Identified five mega trends: automation, modernization, electrification, and sustainability, which are expected to drive future growth [4][6] Financial Performance and Projections - **Growth Targets**: Long-term organic net sales growth target of 3%-5% and EBITDA margin expansion of 50-100 basis points annually [7] - **M&A Aspirations**: Targeting $150 million in revenue from M&A over the long term [8] - **Robotics Revenue Goal**: Ambitious target to grow robotics sales from $85 million in 2025 to $250 million by 2028 [17][18] Innovation and Product Development - **Innovation Focus**: Three main areas: Autonomous Mobile Robots (AMR), small space cleaning solutions, and product line extensions through acquisitions [10][11] - **Recent Product Launches**: Successful entry into outdoor sweeping equipment, with plans for further product introductions [12] ERP Transformation Challenges - **ERP Implementation**: Challenges faced during the ERP rollout in North America, resulting in a $30 million revenue impact due to order entry and fulfillment issues [19][20] - **Recovery Plans**: Focus on stabilizing operations and addressing backlog in Q1, with expectations for improved efficiency in Q2 [23][24] Capital Allocation Strategy - **Investment Priorities**: Emphasis on organic growth, maintaining a disciplined capital allocation strategy, and considering share buybacks when stock prices are favorable [26][27] - **M&A Strategy**: Focus on defending and growing the core business through acquisitions, particularly in robotics and distribution channels [28][29] Market Dynamics and Competitive Landscape - **Competitive Landscape**: Acknowledgment of competition from major players like Nilfisk and Kärcher, with a focus on maintaining a competitive edge through innovation and customer relationships [4][14] - **Market Adaptation**: Continuous assessment of market conditions and competitor offerings to ensure alignment with customer needs and preferences [71] Conclusion - **Outlook**: Despite recent challenges, the company remains optimistic about its growth trajectory, driven by strong market demand and a commitment to innovation and customer service [25][62]

Prenetics Global Conference Call Summary Company Overview - **Company**: Prenetics Global (NasdaqGM:PRE) - **Key Product**: IM8, a health supplement brand launched in December 2024 - **2025 Revenue**: Approximately $92 million, with IM8 contributing $120 million ARR in its first year of operations [1][2] Financial Performance - **2025 Full Year Revenue**: $92 million, with IM8 generating $120 million ARR [1][2] - **Gross Margins**: 63% for IM8 [2] - **Liquidity**: Approximately $160 million in liquid assets, zero debt [2] - **Divestments**: Sold non-core assets including ACT for $72 million, Europa for $13 million, and Insighta to Tencent for $70 million [2][3] Growth Strategy - **Roadmap to Profitability**: Expected by Q4 2027 [2] - **Market Expansion**: IM8 operates in 31 countries, with the U.S. representing 40% of revenue [3][4] - **Customer Base**: Target demographic is ages 30-60, top 10% of household incomes [20][21] - **Marketing Channels**: Currently focused on Meta and Google, with plans to diversify into TikTok, YouTube, and AppLovin [15][24] Product Development - **New Offerings**: Introduction of a three-month subscription option, increasing average order value to approximately $233 [8][9] - **Product Formulation**: Daily Ultimate Essentials and Daily Ultimate Longevity targeting health and aging [12][13] - **Clinical Trials**: Three new clinical trials planned, including collaboration with Mayo Clinic [27] Customer Acquisition and Retention - **Customer Acquisition Cost (CAC)**: $130, with a 24-month Lifetime Value (LTV) of approximately $480 [6] - **Subscription Rate**: 80% of new customers opt for subscriptions, providing predictable revenue [9] Marketing and Brand Ambassadors - **Ambassadors**: Includes David Beckham, Aryna Sabalenka, and Ollie Bearman, who are also shareholders [10][11] - **Social Media Impact**: A viral video reached 233 million views, enhancing brand visibility [11] Future Outlook - **Revenue Guidance for 2026**: Projected revenue of $180 million-$200 million, representing 300% year-over-year growth [17] - **Market Localization**: Plans to enter new markets with tailored marketing strategies [16] - **Long-term Vision**: Aiming for a billion-dollar valuation, with strong brand recognition and customer loyalty [18] Additional Insights - **Bitcoin Holdings**: Currently holding 510 Bitcoins, treated as a treasury asset [3][30] - **Share Buyback Program**: Announced a $40 million share buyback, with $2.75 million already executed by management [32] Conclusion - Prenetics has successfully transformed into a rapidly growing consumer brand, leveraging strong product offerings, strategic marketing, and a clear path to profitability. The company is well-positioned for future growth with significant cash reserves and a focus on expanding its market presence.

Summary of Collegium Pharmaceutical Investor Call Company Overview - **Company**: Collegium Pharmaceutical (NasdaqGS:COLL) - **Event**: Investor Call regarding the acquisition of AZSTARYS from Corium Therapeutics - **Date**: March 19, 2026 Key Points Acquisition Details - Collegium announced the acquisition of AZSTARYS and relevant subsidiaries from Corium Therapeutics for **$650 million** in cash, with potential contingent payments of up to **$135 million** based on sales and regulatory milestones [8][10][19] - The acquisition is expected to close in the **second quarter of 2026** [19] Strategic Rationale - The acquisition significantly expands Collegium's position in the **ADHD** market, adding a second differentiated treatment alongside **Jornay PM** [5][19] - AZSTARYS is expected to extend ADHD revenues into **2037**, five years beyond Jornay PM's expected loss of exclusivity [7][19] - The deal is aligned with Collegium's capital allocation strategy, balancing portfolio expansion and fiscal responsibility [8][19] Financial Impact - The acquisition is projected to be immediately accretive to adjusted EBITDA, with AZSTARYS expected to generate over **$50 million** in pro forma net revenues in the second half of **2026** [10][11] - Collegium generated over **$329 million** in cash from operations in **2025**, indicating strong cash flow to support the acquisition [9] Market Context - The ADHD market is large and growing, with approximately **22 million** patients in the U.S. and **111 million** prescriptions written in **2025** [12] - ADHD prescriptions have been growing at about **8% annually** over the past five years, with **90%** of prescriptions for stimulant medications [12] Product Differentiation - Jornay PM is unique as it is taken at night and provides efficacy upon awakening, while AZSTARYS combines fast and long-acting medications in one capsule [15][17] - Both products target different patient needs, with Jornay PM primarily used in children and adolescents, and AZSTARYS having a more balanced distribution between adults and children [17][18] Sales and Marketing Strategy - Collegium plans to leverage its existing ADHD commercial infrastructure to drive growth for both products, expecting significant cost synergies of over **$50 million** within 12 months post-acquisition [10][19] - The company has a sales force of **180 representatives**, compared to Corium's **100**, which will enhance marketing efforts for AZSTARYS [30][37] Future Outlook - Collegium remains open to further acquisitions in both ADHD and potentially other therapeutic areas, maintaining a focus on capital-efficient opportunities [50][51] - The company aims to maximize the potential of both Jornay PM and AZSTARYS, ensuring broad access and support for the ADHD community [45][54] Additional Insights - Healthcare professionals have rated both Jornay PM and AZSTARYS highly, with **70%** indicating a strong intent to increase prescribing of Jornay PM and **53%** for AZSTARYS [15][16] - The acquisition reflects Collegium's commitment to innovation and financial discipline, aiming to create long-term shareholder value [19][21] Conclusion - The acquisition of AZSTARYS is a strategic move for Collegium, enhancing its ADHD portfolio and positioning the company for sustained growth and shareholder value creation in the biopharmaceutical sector [21][64]

Eni (NYSE:E) 2026 Capital Markets Day March 19, 2026 09:00 AM ET Company ParticipantsAdriano Alfani - CEOAlastair Syme - Managing DirectorAlejandro Vigil - Head of European Integrated Energy & Chemicals Equity ResearchBertrand Hodee - Head of Oil and Gas ResearchBiraj Borkhataria - DirectorClaudio Descalzi - CEOFrancesco Gattei - CFOGuido Brusco - COO of Natural ResourcesJoshua Stone - Head of European EnergyMark Wilson - Managing DirectorMatthew Lofting - Executive DirectorMichele Della Vigna - Managing Di ...